• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常染色体显性多囊肾病患者的原发性醛固酮增多症延迟诊断。

Delayed diagnosis of primary aldosteronism in patients with autosomal dominant polycystic kidney diseases.

机构信息

Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taiwan.

出版信息

J Renin Angiotensin Aldosterone Syst. 2013 Jun;14(2):167-73. doi: 10.1177/1470320312452767. Epub 2012 Jul 12.

DOI:10.1177/1470320312452767
PMID:22791703
Abstract

Hypertension is a frequent early manifestation of autosomal dominant polycystic kidney disease (ADPKD). Several mechanisms can cause hypertension in ADPKD patients, although, primary aldosteronism (PA) as a possible manifestation of hypertension in ADPKD is extremely rare. We retrospectively reviewed the Taiwan Primary Aldosteronism Investigation (TAIPAI) database, which listed a total of 346 patients diagnosed with PA. Of these 346 patients, only three cases of concurrent PA and ADPKD were identified. These patients presented with hypertensive crisis and hypokalemia, and subsequent testing revealed aldosterone-producing adenomas (APAs) that were removed by laparoscopic adrenalectomy. Postoperatively, aldosterone-renin ratios (ARRs) and potassium levels normalized, and blood pressure improved. The diagnosis of PA in ADPKD is extremely challenging because multiple renal cysts can obscure the identification of adrenal adenomas, and ADPKD is associated with hypertension in almost all cases.(1) Because of frequent delays in the diagnosis of PA in ADPKD patients, future prospective studies to screen PA in hypertensive ADPKD patients may be necessary to evaluate the exact prevalence of coexistence of PA and ADPKD.

摘要

高血压是常染色体显性多囊肾病(ADPKD)的早期表现之一。尽管醛固酮增多症(PA)作为 ADPKD 患者高血压的一种表现形式极为罕见,但几种机制可导致 ADPKD 患者发生高血压。我们回顾性分析了台湾原发性醛固酮增多症调查(TAIPAI)数据库,该数据库共列出了 346 例确诊为 PA 的患者。在这 346 例患者中,仅发现 3 例并发 PA 和 ADPKD。这些患者表现为高血压危象和低钾血症,随后的检查发现产生醛固酮的腺瘤(APAs),通过腹腔镜肾上腺切除术切除。术后,醛固酮肾素比值(ARR)和血钾水平恢复正常,血压得到改善。ADPKD 中 PA 的诊断极具挑战性,因为多个肾囊肿可能会掩盖肾上腺腺瘤的识别,而且 ADPKD 几乎在所有情况下都与高血压相关。(1)由于 ADPKD 患者中 PA 的诊断经常延迟,未来可能需要对高血压性 ADPKD 患者进行 PA 筛查的前瞻性研究,以评估 PA 和 ADPKD 共存的确切患病率。

相似文献

1
Delayed diagnosis of primary aldosteronism in patients with autosomal dominant polycystic kidney diseases.常染色体显性多囊肾病患者的原发性醛固酮增多症延迟诊断。
J Renin Angiotensin Aldosterone Syst. 2013 Jun;14(2):167-73. doi: 10.1177/1470320312452767. Epub 2012 Jul 12.
2
Autosomal Dominant Polycystic Kidney Disease and Hypertension Masquerading Primary Aldosteronism.常染色体显性多囊肾病与伪装成原发性醛固酮增多症的高血压
Indian J Nephrol. 2018 Mar-Apr;28(2):167-169. doi: 10.4103/ijn.IJN_330_16.
3
Autosomal dominant polycystic kidney disease complicated by primary aldosteronism. Case report and review of the literature.常染色体显性多囊肾病合并原发性醛固酮增多症。病例报告及文献复习。
Am J Nephrol. 1994;14(3):236-8. doi: 10.1159/000168725.
4
Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease.常染色体显性多囊肾病患者的醛固酮增多症与心血管风险
Medicine (Baltimore). 2016 Jul;95(29):e4175. doi: 10.1097/MD.0000000000004175.
5
Hypertension in autosomal dominant polycystic kidney disease: observational study in 207 patients with a mean follow-up of 107 months.常染色体显性多囊肾病中的高血压:对207例患者的观察性研究,平均随访107个月。
Rev Port Cardiol. 2007 Nov;26(11):1173-82.
6
Kidney impairment in primary aldosteronism.原发性醛固酮增多症中的肾脏损害。
Clin Chim Acta. 2011 Jul 15;412(15-16):1319-25. doi: 10.1016/j.cca.2011.02.018. Epub 2011 Feb 21.
7
Progress in blood pressure control in autosomal dominant polycystic kidney disease.常染色体显性多囊肾病血压控制的进展
Am J Kidney Dis. 2000 Aug;36(2):266-71. doi: 10.1053/ajkd.2000.8970.
8
Borderline hypertensive autosomal dominant polycystic kidney disease patients have enhanced production of renal dopamine. Normalization of renal haemodynamics by DOPA infusion.临界高血压常染色体显性多囊肾病患者肾多巴胺生成增加。通过多巴输注使肾血流动力学正常化。
Nephrol Dial Transplant. 1995;10(8):1332-41.
9
[Two cases of autosomal dominant polycystic kidney diseases who presented bilateral enlarged kidneys and severe hypertension in the neonatal period].两例常染色体显性遗传性多囊肾病患儿在新生儿期出现双侧肾脏增大及重度高血压
Nihon Jinzo Gakkai Shi. 2004 Oct;46(7):719-23.
10
[Blood pressure, functional and morphological study of kidneys in children with autosomal dominant polycystic kidney disease].[常染色体显性多囊肾病患儿的血压、肾脏功能及形态学研究]
Cas Lek Cesk. 1999 Mar 15;138(6):178-84.

引用本文的文献

1
Kidney dysfunction following adrenalectomy in autosomal dominant polycystic kidney disease complicated with primary aldosteronism: A case report.常染色体显性遗传性多囊肾病合并原发性醛固酮增多症患者肾上腺切除术后的肾功能障碍:一例报告
Exp Ther Med. 2017 Aug;14(2):1235-1240. doi: 10.3892/etm.2017.4588. Epub 2017 Jun 13.
2
Hypokalemic Hypertension Leading to a Diagnosis of Autosomal Dominant Polycystic Kidney Disease.低钾性高血压导致常染色体显性遗传性多囊肾病的诊断
Electrolyte Blood Press. 2016 Jun;14(1):11-5. doi: 10.5049/EBP.2016.14.1.11. Epub 2016 Jun 30.
3
Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease.
常染色体显性多囊肾病患者的醛固酮增多症与心血管风险
Medicine (Baltimore). 2016 Jul;95(29):e4175. doi: 10.1097/MD.0000000000004175.
4
Pheochromocytoma as a rare cause of arterial hypertension in a patient with autosomal dominant polycystic kidney disease: A diagnostic and therapeutic dilemma.嗜铬细胞瘤作为常染色体显性遗传性多囊肾病患者动脉高血压的罕见病因:诊断与治疗困境
Int J Surg Case Rep. 2015;14:85-8. doi: 10.1016/j.ijscr.2015.07.015. Epub 2015 Jul 28.
5
A young patient with a family history of hypertension.一位有高血压家族病史的年轻患者。
Clin J Am Soc Nephrol. 2014 Dec 5;9(12):2164-72. doi: 10.2215/CJN.02240314. Epub 2014 Aug 4.